RESEARCH-USE BIOSIMILAR ANTIBODY
Anselamimab
Monoclonal antibody · IgG1
Anselamimab (CAEL-101) is a chimeric monoclonal antibody for systemic light chain (AL) amyloidosis. Anselamimab can promote phagocytic destruction and subsequent clearance of amyloid deposits. Anselamimab can be used in the research of amyloidosis.
TARGETSAA1
YMonoclonal antibody
CATALOGSC-BS-764
CATALOG NUMBERSC-BS-764
MOLECULAR WEIGHTApprox. 144.42 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Anselamimab (CAEL-101) is a chimeric monoclonal antibody for systemic light chain (AL) amyloidosis. Anselamimab can promote phagocytic destruction and subsequent clearance of amyloid deposits. Anselamimab can be used in the research of amyloidosis.
Anselamimab is a recombinant research-use antibody directed against SAA1.